Dalane W. Kitzman

1988–2025 年に発表

別表記
Dalane W Kitzman
263
論文数
52,355
被引用数
120
h 指数
253
i10 指数

被引用数

Dalane W. Kitzman の年別被引用数1988 年: 被引用 3 件1989 年: 被引用 1 件1990 年: 被引用 3 件1991 年: 被引用 7 件1992 年: 被引用 3 件1993 年: 被引用 6 件1994 年: 被引用 4 件1995 年: 被引用 11 件1996 年: 被引用 17 件1997 年: 被引用 21 件1998 年: 被引用 15 件1999 年: 被引用 14 件2000 年: 被引用 38 件2001 年: 被引用 66 件2002 年: 被引用 117 件2003 年: 被引用 134 件2004 年: 被引用 202 件2005 年: 被引用 182 件2006 年: 被引用 205 件2007 年: 被引用 168 件2008 年: 被引用 207 件2009 年: 被引用 197 件2010 年: 被引用 252 件2011 年: 被引用 286 件2012 年: 被引用 297 件2013 年: 被引用 271 件2014 年: 被引用 378 件2015 年: 被引用 414 件2016 年: 被引用 436 件2017 年: 被引用 465 件2018 年: 被引用 426 件2019 年: 被引用 1,441 件2020 年: 被引用 1,516 件2021 年: 被引用 1,688 件2022 年: 被引用 1,519 件2023 年: 被引用 1,173 件2024 年: 被引用 2,578 件2025 年: 被引用 1,903 件2026 年: 被引用 57 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 5,311 件、この内訳の 25.9%イギリス: 引用元論文 1,467 件、この内訳の 7.2%イタリア: 引用元論文 1,204 件、この内訳の 5.9%中国: 引用元論文 1,154 件、この内訳の 5.6%ドイツ: 引用元論文 941 件、この内訳の 4.6%カナダ: 引用元論文 925 件、この内訳の 4.5%オランダ: 引用元論文 770 件、この内訳の 3.8%オーストラリア: 引用元論文 662 件、この内訳の 3.2%フランス: 引用元論文 592 件、この内訳の 2.9%スペイン: 引用元論文 571 件、この内訳の 2.8%日本: 引用元論文 550 件、この内訳の 2.7%スウェーデン: 引用元論文 438 件、この内訳の 2.1%
0%25.9%その他 28.8%

分野

  • Medicine82.4%
  • Biochemistry, Genetics and Molecular Biology10.9%
  • Immunology and Microbiology1.1%
  • Engineering1%
  • Agricultural and Biological Sciences0.9%
  • Health Professions0.8%
  • その他2.9%

トピック

  • Cardiovascular Function and Risk Factors10.8%
  • Heart Failure Treatment and Management7.5%
  • Cardiovascular and exercise physiology3.8%
  • Diabetes Treatment and Management3.1%
  • Cardiac Valve Diseases and Treatments2.4%
  • Cardiac Imaging and Diagnostics2.4%
  • その他70%

共著者

全論文

検索で開く
  1. Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mark C. Petrie - New England Journal of Medicine 2023 被引用: 1,436

  2. Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennis Wolf, Sanjiv J. Shah - New England Journal of Medicine 2024 被引用: 632

  3. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets

    著者: , , , , , - Cardiovascular Research 2022 被引用: 413

  4. Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennis Wolf, Mikhail Kosiborod - The Lancet 2024 被引用: 323

  5. Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction

    著者: , , , , , , , - JAMA 2016 被引用: 879

  6. The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2021 被引用: 604

  7. Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2023 被引用: 188

  8. A mechanism by which gut microbiota elevates permeability and inflammation in obese/diabetic mice and human gut

    著者: , , , , , , , , , , - Gut 2023 被引用: 261

  9. Gut microbiome and aging: Physiological and mechanistic insights

    著者: , , , , , , , , , - Nutrition and Healthy Aging 2017 被引用: 655

  10. Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

    著者: , , , , , , , , , , , , , , , , , , - The Lancet 2024 被引用: 264

  11. Physical Rehabilitation for Older Patients Hospitalized for Heart Failure

    著者: , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 547

  12. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Margaret B. Fraenkel, Martin Gallagher, Timothy M. E. Davis, Shamasunder Acharya, Duncan Cooke, Michael Suranyi, Simon D. Roger, Nigel D. Toussaint, Carol A. Pollock, Doris Chan, Stephen Stranks, Richard J. MacIsaac, Zoltán Endre, Alice Schmidt, Rudolf Prager, Gert Mayer, Xavier Warling, Michel Jadoul, Jean Hougardy, Chris Vercammen, Bruno Van Vlem, Pieter Gillard, Adriana Costa e Forti, João Borges, Luis Santos Canani, Freddy G. Eliaschewitz, Silmara Leite, Fadlo Fraige Filho, Raphael Paschoalin, José A. Moura-Neto, Luciane Mônica Deboni, Irene de Lourdes Noronha, Cíntia Cercato, Carlos Alberto Prompt, Maria Teresa Zanella, Nelson Rassi, Domingos O. d’Avila, Rosângela Milagres, João Soares Felício, Roberto Pecoits‐Filho, Miguel C. Riella, João Eduardo Nunes Salles, Elizete Keitel, Sérgio Antônio Draibe, Celso Amodeo, J. T. Youmbissi, Louise Roy, Serge Cournoyer, Shivinder Jolly, Vincent Pichette, Gihad Nesrallah, Harpreet S. Bajaj, Hasnain Khandwala, Ronnie Aronson, Richard Goluch, Paul Kwong Hang Tam, Christian Rabbat, Sheldon W. Tobe, G. HOWARD BAILEY, S. P. Chow, A Castillo, Alfredo Danin Vargas, Fernando González, Rodrigo Muñoz, Vicente Gutiérrez, Gonzalo Godoy, Hongwen Zhao, Zhangsuo Liu, Ming‐Hui Zhao, Xiaohui Guo ほか 610 名 - The Lancet 2019 被引用: 612

  13. Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction

    著者: , , , , , , - Circulation 2016 被引用: 980

  14. Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure

    著者: , , , , , , , , , , , , , , , , , - JAMA 2009 被引用: 2,167

  15. Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years

    著者: , , , , , , , , , , , , , , , , , , , , , , , , - JAMA 2016 被引用: 1,239

  16. Research Priorities for Heart Failure With Preserved Ejection Fraction

    著者: , , , , , , , , , , , , , , , , , - Circulation 2020 被引用: 417

  17. Home-Based Cardiac Rehabilitation: A Scientific Statement From the American Association of Cardiovascular and Pulmonary Rehabilitation, the American Heart Association, and the American College of Cardiology

    著者: , , , , , , , , , , , - Circulation 2019 被引用: 558

  18. Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome

    著者: , , , , , , , , , - Scientific Reports 2018 被引用: 368

  19. Frailty Is Intertwined With Heart Failure

    著者: , , - JACC Heart Failure 2019 被引用: 325

  20. Lipoteichoic acid from the cell wall of a heat killed Lactobacillus paracasei D3-5 ameliorates aging-related leaky gut, inflammation and improves physical and cognitive functions: from C. elegans to mice

    著者: , , , , , , , , , , , - GeroScience 2019 被引用: 212

  21. Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations

    著者: , , , , , , , , , , , - Circulation 2012 被引用: 814

  22. Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of Cardiology

    著者: , , , , , , , , , , , , , , - Circulation 2023 被引用: 121

  23. Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients With Heart Failure With Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial

    著者: , , , , , , , , , , , , , , - Circulation 2023 被引用: 92

  24. Metformin Reduces Aging-Related Leaky Gut and Improves Cognitive Function by Beneficially Modulating Gut Microbiome/Goblet Cell/Mucin Axis

    著者: , , , , , , , , , , , , - The Journals of Gerontology Series A 2020 被引用: 144